- Home
- GOVX
GOVX
GeoVax Labs Inc.
as 07-26-2024 4:00pm EST
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | SMYRNA |
| Market Cap: | 7.0M | IPO Year: | N/A |
| Target Price: | $15.33 | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -14.51 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.09 - $9.75 | Next Earning Date: | 08-07-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest GeoVax Labs Inc. News
GOVX Breaking Stock News: Dive into GOVX Ticker-Specific Updates for Smart Investing
GlobeNewswire
10 days ago
Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
NewMediaWire
10 days ago
GeoVax to Present at the Emerging Growth Conference on July 18, 2024
MT Newswires
10 days ago
Top Premarket Gainers
NewMediaWire
15 days ago
GeoVax to Raise Approximately $3.1 Million of Gross Proceeds in Offering Priced At-the-Market
NewMediaWire
17 days ago
GeoVax Provides First Half 2024 Business Update
NewMediaWire
a month ago
GeoVax Partners with Allucent to Conduct Phase 2b Clinical Study of Next-Generation COVID-19 Vaccine Candidate with Funding from BARDA
NewMediaWire
a month ago
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1
MT Newswires
2 months ago
Top Premarket Decliners
Compare GOVX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GOVX GeoVax Labs Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.